Plasma Cytokine Profiles in Females With Irritable Bowel Syndrome and Extra-Intestinal Co-Morbidity
- 1 October 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 105 (10), 2235-2243
- https://doi.org/10.1038/ajg.2010.159
Abstract
Irritable bowel syndrome (IBS) is a functional disorder that is associated with a number of extra-intestinal co-morbidities and a pro-inflammatory profile. This study was designed to examine the cytokine profile among a group of IBS patients with the extra-intestinal co-morbidities fibromyalgia, premenstrual dysmorphic disorder, and chronic fatigue syndrome. In all, 100 female IBS patients with these co-morbidities, 21 IBS subjects without co-morbidity (“pure” IBS; Rome II), and 54 age-matched female controls took part in the study. Blood was drawn for measurement of the plasma cytokines interleukin (IL)-1β, IL-6, IL-8, IL-10, IL-12p70, IL-13, tumor necrosis factor (TNF)α, and interferon γ. The presence of the selected extra-intestinal manifestations was assessed using standard international criteria. Patients with IBS have increased plasma levels of IL-6 and IL-8; those with these extra-intestinal co-morbidities were found to have, in addition, increased levels of IL-1β and TNFα. No associations were evident between cytokine profiles and the nature of the co-morbidity or number of extra-intestinal co-morbidities present. Although IBS is characterized by a pro-inflammatory profile featuring the pro-inflammatory cytokines IL-6 and IL-8, IBS patients with certain extra-intestinal co-morbid conditions are distinguished by additional elevations in IL-1β and TNFα.This publication has 36 references indexed in Scilit:
- Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal periodBritish Journal of Pharmacology, 2002
- Comorbid conditions in patients with irritable bowel syndrome: Data from A national IBS awareness registryGastroenterology, 2001
- Fibromyalgia in The Irritable Bowel Syndrome: Studies of Prevalence and Clinical ImplicationsThe American Journal of Gastroenterology, 1999
- The Sense of Coherence Index and the Irritable Bowel Syndrome: A Cross-Sectional Comparison among Irritable Bowel Syndrome Patients with and without Coexisting Fibromyalgia, Irritable Bowel Syndrome Non-Patients, and ControlsScandinavian Journal of Gastroenterology, 1999
- Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndromeJournal of Psychosomatic Obstetrics & Gynecology, 1996
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationThe New England Journal of Medicine, 1995
- Central Nervous System Effects of the Neurohypophyseal Hormones and Related PeptidesFrontiers in Neuroendocrinology, 1993
- Irritable bowel-type symptoms in HMO examineesDigestive Diseases and Sciences, 1993
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990
- Systematic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosteroneLife Sciences, 1988